You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Oesophageal cancer

Tislelizumab with chemotherapy for untreated advanced oesophageal squamous cell cancer ID5113

  • In development
  • Reference number: GID-TA11025
  • Expected publication date: TBC
  • Project information
  • Project documents

27131-Tislelizumab-Chemotherapy-for-Oesophageal-Cancer-V1.0-MAR22-NON-CONF.pdf (nihr.ac.uk)

Back to top